Over the past decade, scientists have discovered specific inherited
factors, or genes, that can contribute to the development of some
forms of breast, ovarian, colorectal, and other types of cancer.
Our experts in cancer risk and genetic counseling can provide individuals
and families with information on risk factors and potential genetic
testing options. A complete personal and family history of cancer
will be used to explain how cancer risk can travel within families
and identified those who would benefit from genetic testing.
The most common testing for breast and ovarian cancer is the BRCA1 & BRCA2
test. However, there are other genes that may also play a role
so through genetic counseling the most appropriate testing option
can be determined. According to the National Cancer Institute, “The
likelihood that breast and/or ovarian cancer is associated with
BRCA1 or BRCA2 is highest in families with a history of multiple
cases of breast cancer, cases of both breast and ovarian cancer,
one or more family members with two primary cancers (original tumors
at different sites), or an Ashkenazi (Eastern European) Jewish
background. However, not every woman in such families carries an
alteration in BRCA1 or BRCA2, and not every cancer in such families
is linked to alterations in these genes.” Most genetic testing
is performed from a blood test and will take about a month to receive
a result after your insurance has approved the test.
To determine if one is a candidate for genetic testing, we ask
that patients schedule a consultation. Genetic counseling includes
a assessment of individual risk factors and/or history of cancer,
family history of cancer, and a comprehensive review of options
based on level of cancer risk, as well as an update on federal
legislation against genetic discrimination.
For those who meet criteria for genetic testing, blood can be
drawn, informed consent signed, and insurance pre-certification
(if applicable) will be completed with assistance from the outside
laboratory performing the test. Results and follow-up recommendations
will be provided to the patient and other medical providers (as
indicated by the patient).
Click
here for more information on BRCA 1 & 2 testing.